Updated July 17, 2009
LabCorp formally launches $106M buyout of bioscience firm
Post a comment
Print this storyE-mail story
Share
BURLINGTON, N.C. —
LabCorp (NYSE: LH) began its takeover of Monogram Biosciences (Nasdaq: MGRM) with a formal offer of $4.55 per share on Wednesday.
The deal is expected to cost LabCorp $106 million.
The companies agreed to acquisition terms last week.
Monogram focuses on treatments and testing for infectious diseases, including HIV, cancer and other ailments.
Featured
Hot Off The Wire
- Red Hat's new Fedora lead; Cree LED breakthrough; Google, Cisco top 'green' list; Oracle rejects SAP settlement; Yahoo board shakeup
- Will Cisco report progress in its turnaround efforts?
- Cisco server fire threat; Lenovo Android upgrade; cloud startup vs. Cisco; Epic's Blesinski to host awards; Google 'Solve for X'
E-mail Preferences
